Anticoagulation and thromboembolic risk in critically ill patients with trigger-induced atrial fibrillation—A systematic review and meta-analysis
Jasper Koolwijk(Radboud University Nijmegen), Luuk Otterspoor(Radboud University Nijmegen), Ashley J.R. De Bie(Radboud University Nijmegen), Mileen van de Kar(Radboud University Nijmegen), Harm‐Jan de Grooth(Amsterdam UMC Location Vrije Universiteit Amsterdam), Marcel van ’t Veer(Radboud University Nijmegen), Olaf L. Cremer(University Medical Center Utrecht), Harry J.G.M. Crijns(University Medical Center), Lukas Dekker(Radboud University Nijmegen), Brittney A van der Woude(University Medical Center Utrecht), R. Arthur Bouwman(Amsterdam UMC Location Vrije Universiteit Amsterdam)
Cited by 0
Related Papers
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary
|Journal of the American College of Cardiology|2001|1.4k
Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation
|New England Journal of Medicine|2009|1.1k
Increased Mortality after Dronedarone Therapy for Severe Heart Failure
|New England Journal of Medicine|2008|962
Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study
|The Lancet Respiratory Medicine|2017|645